GeneDx Holdings Corp. (WGS)
68.53
-2.99
(-4.18%)
USD |
NASDAQ |
Oct 07, 16:00
68.48
-0.05
(-0.07%)
After-Hours: 20:00
GeneDx Holdings Profit Margin (Quarterly) : -15.50% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.50% |
| March 31, 2026 | -61.92% |
| December 31, 2025 | -14.60% |
| September 30, 2025 | -6.54% |
| June 30, 2025 | 10.53% |
| March 31, 2025 | -7.49% |
| December 31, 2024 | 5.69% |
| September 30, 2024 | -10.81% |
| June 30, 2024 | -41.37% |
| March 31, 2024 | -32.42% |
| December 31, 2023 | -44.89% |
| September 30, 2023 | -79.33% |
| Date | Value |
|---|---|
| June 30, 2023 | -95.92% |
| March 31, 2023 | -141.4% |
| December 31, 2022 | -503.3% |
| September 30, 2022 | -93.21% |
| June 30, 2022 | -237.1% |
| March 31, 2022 | -142.6% |
| December 31, 2021 | -69.52% |
| September 30, 2021 | 75.80% |
| June 30, 2021 | -98.18% |
| March 31, 2021 | -298.7% |
| December 31, 2020 | -196.5% |
| September 30, 2020 | -146.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Twist Bioscience Corp. | -29.61% |
| CS Diagnostics Corp. | -- |
| Aibotics, Inc. | -- |
| Intellia Therapeutics, Inc. | -1.39K% |
| 10X Genomics, Inc. | -11.87% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -38.65% |
| Return on Assets | -21.14% |
| Return on Invested Capital | -25.88% |
| Gross Profit Margin (Quarterly) | 64.05% |
| Operating Margin (Quarterly) | -12.37% |
| Return on Net Operating Assets | -31.72% |